Maxgalin 50 Capsule contains Pregabalin 50mg, an anticonvulsant and neuropathic pain agent used primarily to manage neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury. It is also indicated as adjunctive therapy for partial-onset seizures in adults. Pregabalin acts by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby modulating calcium influx and reducing the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P. This mechanism contributes to its analgesic, anxiolytic, and anticonvulsant effects. Maxgalin 50 Capsule is administered orally, with dosing individualized based on the patient's clinical response and tolerability. Common adverse effects include dizziness, somnolence, dry mouth, edema, blurred vision, and weight gain. Caution is advised in patients with renal impairment, as dose adjustment may be necessary. It is contraindicated in patients with known hypersensitivity to pregabalin or any of its excipients. Pregabalin should be used under medical supervision, with gradual dose titration to minimize adverse effects. Abrupt discontinuation should be avoided to prevent withdrawal symptoms. Maxgalin 50 Capsule offers an effective therapeutic option for neuropathic pain and seizure management when used appropriately.